About this episode
从实验室到临床，干细胞治疗为全球数千万自闭症家庭带来新希望。2025年8月11日，日本厚生劳动省正式批准了Biostar研究所的“天使干细胞疗法”用于自闭症谱系障碍（ASD）治疗。
这是全球首个获得国家级药监部门批准的自闭症干细胞治疗方案，标志着再生医学在神经发育障碍领域取得重大突破。自闭症谱系障碍患者及其家庭，迎来了一个全新的治疗选择。
Get every episode summarized
Each time 天方烨谈 publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
